Terug
Dagbereik
€ 151,45
€ 154,69
52-Weeksbereik
€ 101,00
€ 159,42
Volume
586.573
50D / 200D Gem.
€ 134,83
/
€ 131,28
Vorige Slotkoers
€ 152,21
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 13,7 | 0,3 |
| P/B | — | 2,9 |
| ROE % | — | 3,7 |
| Net Margin % | 5,5 | 3,8 |
| Rev Growth 5Y % | 4,1 | 10,0 |
| D/E | — | 0,2 |
Koersdoel Analisten
Hold
€ 168,67
+10.0%
Low: € 158,00
High: € 190,00
Forward K/W
10,8
Forward WPA
€ 14,13
WPA Groei (sch.)
+0,0%
Omzet Sch.
14 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2029 |
€ 18,12
€ 17,77 – € 18,76
|
16 B | 1 |
| FY2028 |
€ 18,29
€ 17,93 – € 18,94
|
15 B | 1 |
| FY2027 |
€ 16,27
€ 16,21 – € 16,34
|
14 B | 4 |
Belangrijkste Punten
Revenue grew 4,10% annually over 5 years — modest growth
Earnings declined -20,24% over the past year
Generating 1,31B in free cash flow
P/E of 13,72 — trading at a low valuation
Cash machine — converts 175,50% of earnings into free cash flow
Capital efficient — spends only 4,22% of revenue on capex
Groei
Revenue Growth (5Y)
4,10%
Revenue (1Y)6,46%
Earnings (1Y)-20,24%
FCF Growth (3Y)-6,24%
Kwaliteit
Return on Equity
N/A
ROIC10,47%
Net Margin5,47%
Op. Margin14,74%
Veiligheid
Debt / Equity
N/A
Current Ratio1,29
Interest Coverage3,66
Waardering
P/E Ratio
13,72
P/B RatioN/A
EV/EBITDA12,20
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6,46% | Revenue Growth (3Y) | 6,01% |
| Earnings Growth (1Y) | -20,24% | Earnings Growth (3Y) | 3,92% |
| Revenue Growth (5Y) | 4,10% | Earnings Growth (5Y) | -6,53% |
| Profitability | |||
| Revenue (TTM) | 13,64B | Net Income (TTM) | 746,80M |
| ROE | N/A | ROA | 4,27% |
| Gross Margin | 27,00% | Operating Margin | 14,74% |
| Net Margin | 5,47% | Free Cash Flow (TTM) | 1,31B |
| ROIC | 10,47% | FCF Growth (3Y) | -6,24% |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 1,29 |
| Interest Coverage | 3,66 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 13,72 | P/B Ratio | N/A |
| P/S Ratio | 0,75 | PEG Ratio | -1,11 |
| EV/EBITDA | 12,20 | Dividend Yield | 0,00% |
| Market Cap | 10,25B | Enterprise Value | 24,54B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 13,64B | 12,82B | 12,14B | 11,61B | 11,62B |
| Net Income | 746,80M | 936,34M | 691,54M | 560,40M | 978,45M |
| EPS (Diluted) | 9,51 | 10,73 | 7,42 | 5,71 | 8,90 |
| Gross Profit | 3,68B | 4,22B | 3,82B | 3,40B | 3,65B |
| Operating Income | 2,01B | 2,09B | 1,60B | 1,34B | 1,80B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 17,48B | 17,29B | 16,89B | 16,93B | 17,12B |
| Total Liabilities | 16,32B | 15,19B | 14,15B | 14,70B | 14,75B |
| Shareholders' Equity | -651,08M | 121,12M | 1,06B | 712,33M | 755,51M |
| Total Debt | 15,05B | 12,07B | 11,12B | 11,82B | 11,98B |
| Cash & Equivalents | 757,75M | 794,93M | 380,06M | 244,09M | 461,90M |
| Current Assets | 4,06B | 3,75B | 3,14B | 3,16B | 3,17B |
| Current Liabilities | 3,14B | 2,97B | 2,64B | 2,62B | 2,40B |